好招商食品网讯 2024年4月12日,欧盟食品安全局就一种谷氨酰胺酶(glutaminase)的安全性评价发布意见。
据了解,这种食品酶是由转基因地衣芽孢杆菌菌株NZYM-JQ生产的,旨在用于六种食品生产过程。
经过评估,专家小组认为,在预期的使用条件下,不能排除饮食暴露引起过敏反应的风险,特别是对桦树和橡树花粉过敏的个体。根据所提供的数据,评估小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
The food enzyme glutaminase (l-glutamine amidohydrolase EC 3.5.1.2) is produced with the genetically modified Bacillus licheniformis strain NZYM-JQ by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The production strain met the requirements for the qualified presumption of safety (QPS). The food enzyme is free from viable cells of the production organism and its DNA. The enzyme under assessment is intended to be used in six food manufacturing processes. Dietary exposure was estimated to be up to 0.148 mg TOS/kg body weight per day in European populations. Given the QPS status of the production strain and the absence of concern resulting from the food enzyme manufacturing process, toxicological studies were not considered necessary. A search was made for the similarity of the amino acid sequence to those of known allergens and one match with a pollen allergen was found. The Panel considered that the risk of allergic reactions by dietary exposure cannot be excluded, particularly for individuals sensitised to birch and oak pollen. The Panel concluded that the food enzyme does not give rise to safety concerns under the intended conditions of use.
TAGS:
芽孢 安全局 转基因 杆菌 食品安全
免责声明:本站部分文章转载自网络,图文仅供行业学习交流使用,不做任何商业用途。文章仅代表原作者个人观点,其原创性及文章内容中图文的真实性、完整性等未经本站核实,仅供读者参考。
上一篇: 欧盟评估扩展使用非转基因苍白气芽孢杆菌菌株AE-SAS生产的4-α-葡聚糖转移酶的安全性
下一篇: 欧盟评估转基因酿酒酵母菌株CBS615.94生产的α-半乳糖苷酶的安全性